Missouri's only abortion clinic on Friday won its case against the state's health department to remain open, as an independent arbiter found the agency was unjustified in denying the clinic's application to renew its license.
France's coronavirus death toll rose by less than a 100 for the ninth day running on Friday, as the country is gearing up for a new easing of lockdown measures.
At least 25 imported cases of the coronavirus have been detected in Spain over the past month, health authorities said on Friday, despite a strict ban on foreign tourism imposed since mid-March.
Sanofi has temporarily stopped recruiting new COVID-19 patients for two clinical trials on hydroxychloroquine and will no longer supply the anti-malaria drug to treat COVID-19 until concerns about safety are cleared up, it said on Friday.
South Africa is conducting extensive testing and investigations to curb the spread of African Swine Fever (ASF) after it was detected in the country's Eastern Cape province, the third known outbreak this year, government said on Friday.
European and South Korean authorities are vying for Gilead Sciences' potential COVID-19 treatment, remdesivir, even though the drugmaker has yet to gain regulatory approval in either market and is still ramping up production of the anti-viral drug.
Authorities in Lombardy, the northern Italian region at the centre of one of Europe's worst coronavirus outbreaks, have rebuffed requests to top up health service budgets to cover huge increases in services from homecare operators.
The U.S. Food and Drug Administration on Friday approved Abbvie Inc's oral treatment for managing heavy menstrual bleeding associated with fibroids in premenopausal women.
Thirty-seven countries and the World Health Organization (WHO) appealed on Friday for common ownership of vaccines, medicines and diagnostic tools to tackle the global coronavirus pandemic, taking aim at patent laws they fear could become a barrier to sharing crucial supplies.
Sanofi has temporarily stopped recruiting new COVID-19 patients for its two clinical trials on hydroxychloroquine and will not supply the anti-malaria drug to treat COVID-19 until concerns about safety are cleared up, it said on Friday.